Lingua: Inglese
Editore: Lap Lambert Academic Publishing, 2012
ISBN 10: 3659251763 ISBN 13: 9783659251764
Da: Revaluation Books, Exeter, Regno Unito
EUR 96,06
Quantità: 1 disponibili
Aggiungi al carrelloPaperback. Condizione: Brand New. 72 pages. 8.66x5.91x0.17 inches. In Stock.
Lingua: Inglese
Editore: LAP Lambert Academic Publishing, 2012
ISBN 10: 3659251763 ISBN 13: 9783659251764
Da: preigu, Osnabrück, Germania
EUR 43,30
Quantità: 5 disponibili
Aggiungi al carrelloTaschenbuch. Condizione: Neu. Formulation And Optimization Of Process Parameters Of Omeprazole DR Pallets | A Case Study For Yield Improvement | Yaswanth Allamneni (u. a.) | Taschenbuch | Englisch | LAP Lambert Academic Publishing | EAN 9783659251764 | Verantwortliche Person für die EU: preigu GmbH & Co. KG, Lengericher Landstr. 19, 49078 Osnabrück, mail[at]preigu[dot]de | Anbieter: preigu.
Lingua: Inglese
Editore: LAP LAMBERT Academic Publishing, 2012
ISBN 10: 3659251763 ISBN 13: 9783659251764
Da: moluna, Greven, Germania
EUR 41,67
Quantità: Più di 20 disponibili
Aggiungi al carrelloKartoniert / Broschiert. Condizione: New. Dieser Artikel ist ein Print on Demand Artikel und wird nach Ihrer Bestellung fuer Sie gedruckt. Autor/Autorin: Allamneni YaswanthWorking as Executive at Research and Development Department (Technology Transfer) in Natco Pharma Limited. Stood college first in M. Pharmacy under West Bengal University of Technology,West Bengal. Published various.
Lingua: Inglese
Editore: LAP Lambert Academic Publishing, 2012
ISBN 10: 3659251763 ISBN 13: 9783659251764
Da: AHA-BUCH GmbH, Einbeck, Germania
EUR 49,59
Quantità: 2 disponibili
Aggiungi al carrelloTaschenbuch. Condizione: Neu. nach der Bestellung gedruckt Neuware - Printed after ordering - The main aim of the present investigation was to observe the entire manufacturing process and to find out the problems occurring during each step of the process and to rectify those. The study involves the improvement in yield by changing (or) rectifying the problems occurred in machine, man, method, material by keeping in mind various formulation aspects relating to it. Omeprazole is prototype member of new class of substituted Benzimidazoles, which inhibits the final common step in gastric acid secretion. In the present investigation, various formulation aspects were studied for developing a pharmaceutical equivalent, stable, cost improved and quality improved formulation of enteric coated omeprazole pellets comparable with innovator and optimize certain process parameters to get maximum yield of the product during large scale manufacturing. The basic goal of drug therapy is to achieve a steady blood or tissue level of the drug at specific site which will be therapeutically effective and non-toxic.